Don Wilson Email & Phone Number

Research Triangle Park, Nc

Endacea recently formed a subsidiary corporation, Endacea Diagnostics, Inc. (Endacea Dx) to develop and commercialize the Company's endotoxin assay as a biomarker for sepsis and for other uses.

Endacea, Inc. (RTP, NC), an emerging biopharmaceutical company, is developing a series of proprietary A1 adenosine receptor (AR) antagonists as drug candidates for a number of medical indications, including: 1) inflammation, including sepsis and asthma; and 2) renal impairment, including acute or worsening renal impairment associated with acute or chronic heart failure and cisplatin-induced renal impairment. In addition, Endacea is developing a sensitive and specific biomarker for sepsis as a companion diagnostic for Endacea's i.v. anti-sepsis drug candidate and for other uses.Endacea’s lead compound A1 AR antagonist, L-97-1, is a water-soluble, orally bioavailable “best in class” A1 AR antagonist late preclinical drug candidate. Endacea’s patent estate includes issued U.S. patents for compositions of matter for L-97-1and follow-on A1 AR antagonists, as well as methods of use patents, e.g. sepsis, and pending applications for methods of use for renal impairment and for a new endotoxin assay. For additional information, see www.endacea.com.

Dominant provider of instructor led computer technical training in the Baltimore metropolitan area. Novell Authorized Education Center, Microsoft Authorized Technical Education Center. 1996 Inc. 500 company. Sold in 1996 to Global Knowledge Network, a roll-up owned by Welsh, Carson, Anderson & Stowe.

Micro Wholesalers, Inc. evolved into MWI Training Services, Inc. following the rapid growth of the Company's IT and network training business.

Jd

Mba

Ab, Economics

Activities and Societies: Phi Beta Kappa

Education record